Mumbai, November 16, 2018: Boehringer Ingelheim, one of the world’s leading pharmaceutical company, today inaugurated ‘first-of-its-kind’ facility for children with multiple…
Expanded partnership will help co-market two oral anti—diabetic drugs Gibtulio Met® (Empagliflozin + Metformin) andAjaduo®(Empagliflozin+ Linagliptin ) Gibtulio Met® has potential…